Perfluorohexyloctane ophthalmic solution in the treatment of dry eye
August 22nd 2024At the World Ophthalmology Congress in Vancouver, Canada, John D. Sheppard, MD, MMSc, FACS, presented data on perfluorohexyloctane ophthalmic solution in the treatment of dry eye. He sat down with Ophthalmology Times to discuss the topic in further detail.
Tolerability of cosmetic products on the ocular surface
August 21st 2024At the World Ophthalmology Congress in Vancouver, Canada, Mahnia Madan, OD, FAAO, presented a paper on the tolerability of cosmetic products on the ocular surface. She sat down with Ophthalmology Times to discuss the topic in further detail.
ASRS 2024: Retinal vascular changes in patients with Alzheimer's Disease
July 28th 2024Sruthi Arepalli, MD, spoke about her presentation, "Assessing retinal vascular changes in Alzheimer's disease with radiomics: A preliminary study of fundus photography" at the annual ASRS meeting in Stockholm, Sweden.
ASRS 2024: Novel approach to myopic traction maculopathy
July 27th 2024Nikoloz Labauri, MD, FVRS, founder of DAVINCI Eye Clinic in Tbilisi, Georgia, discusses his presentation, "Suspensory Macular Buckling for Myopic Traction Maculopathy" at this year's American Society of Retina Specialists (ASRS) meeting in Stockholm, Sweden
ASRS 2024: Results of the LIGHTSITE III study
July 26th 2024Eleonora Lad, MD, PhD, spoke about her presentation, "Multiwavelength photobiomodulation significantly reduces risk for vision loss and onset of geographic atrophy in dry age-related macular degeneration" at this year's American Society of Retina Specialists (ASRS) meeting in Stockholm, Sweden.
ASRS 2024: Intraoperative fluorescein angiography improving outcomes in diabetic vitrectomy
July 25th 2024Alan Franklin, MD, PhD, FASRS, spoke about his presentation, "Intraoperative Fluorescein Angiography Reduces the Rate of Postoperative Vitreous Hemorrhage" at this year's American Society of Retina Specialists (ASRS) meeting in Stockholm, Sweden.
ASRS 2024: Socioeconomic barriers and visual outcomes
July 24th 2024Sally S. Ong, MD, spoke about her study on the impact of individual and neighborhood-level social determinants of health on vision and foveal status at presentation in patients with rhegmatogenous retinal detachments at the annual ASRS meeting in Stockholm, Sweden.
ASRS 2024: Long-term results of using indocyanine green to peel internal lining membrane
July 24th 2024John T. Thompson, MD, spoke about his presentation, "Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling" at the annual ASRS meeting in Stockholm, Sweden.
ASRS 2024: Characterization of HK1 mutations and retinitis pigmentosa
July 23rd 2024Patrick C. Staropoli, MD, discussed his presentation on the clinical characterization of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa while attending the annual ASRS meeting in Stockholm, Sweden.
ASRS 2024: Real-world safety and efficacy of aflibercept 8 mg in the treatment of nAMD
July 20th 2024Deepak Sambhara, MD, shared an overview of his paper-on-demand, which covered real-world safety and efficacy of aflibercept, 8 mg in the treatment of neovascular age-related macular degeneration at the annual ASRS meeting in Stockholm, Sweden.